[ad_1]
An opioid analgesic The other pills spread on the table with a reflective surface with a gradient
KANSAS CITY, MB – Chief of Kansas City Small Pharmaceutical Company Defends After Financial Publication Reports Moral Requirement to Increase by 400% the Price of an Antibiotic years.
The Kansas City Star reports that Nostrum Laboratories founder Nirmal Mulye said his comments on the London Financial Times had been taken out of context. The publication says that it sticks to the story.
Scott Gottlieb, Commissioner of the Food and Drug Administration, strongly criticized the report.
The challenge is Nostrum's project to increase the price of nitrofurantoin, an antibiotic used to treat bladder infections.
Reached by phone Thursday at his home in New Jersey, Mulye said he was talking about his obligations to his employees. He is worried about keeping his company afloat.
Source link
